secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2023-09-05T23:59:59+00:00
Accession:  0001493152-23-031568
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 1.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo Pharmaceuticals' Acting CFO resigns as advisory agreement with Potrero terminated
--------------------------------------------------------------------------------

- Potrero Hill Advisors terminated Master Services Agreement with Anebulo effective Sept 28, 2023.
- Sandra Gardiner resigned as Acting CFO, principal financial and accounting officer, effective Sept 28.
- Gardiner offered limited transition support to successor post-termination, subject to further discussion.
- Company warns of risk to financing/accounting function if successor not found by termination date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315223031568/0001493152-23-031568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315223031568/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer